How to Manage Dental Surgery with Glanzmann Thrombasthenia
At a Glance
Wisdom teeth removal for patients with Glanzmann Thrombasthenia requires a hospital setting and a multidisciplinary team to manage severe bleeding risks. Treatment involves IV clotting medications like rFVIIa, specialized oral packing, and tranexamic acid mouthwash. Strictly avoid NSAIDs for pain.
In this answer
5 sections
Because Glanzmann Thrombasthenia (GT) prevents platelets from clumping together, major dental work—such as wisdom teeth removal or other extractions—represents a significant medical event, not a routine dentist visit. The mouth is highly vascular and naturally contains enzymes in saliva that break down blood clots, making extractions particularly risky for prolonged bleeding [1][2]. Safely removing teeth requires performing the procedure in a hospital setting with a coordinated team consisting of an oral surgeon and a hematologist [3][4]. To prevent severe hemorrhage, your medical team will use a combination of systemic treatments (like platelet transfusions or recombinant factor VIIa) to help the blood clot, alongside local tools (like special stitches, surgical stents, and antifibrinolytic mouthwashes) to protect the clot once it forms [5][6].
Building the Right Team and Setting
Wisdom teeth extraction for someone with GT should not be done in a standard outpatient dental clinic [6][1]. It requires a multidisciplinary approach:
- Hematologist: Manages your bleeding risk and oversees systemic clotting treatments [3][4].
- Oral and Maxillofacial Surgeon: Performs the extraction using techniques designed to minimize tissue trauma and bleeding [1][2].
- Anesthesiologist: Ensures safe sedation and manages airway risks, which are elevated if bleeding occurs in the mouth [3][7].
Because the bleeding risk remains high in the hours and days following surgery, expect an overnight or multi-day hospital admission for close observation rather than going home the same day [4][6].
Before the procedure, your hematologist will likely screen your blood for alloantibodies (anti-platelet or anti-HLA antibodies) [8][9]. These antibodies can develop from past blood or platelet transfusions and cause your immune system to destroy new donor platelets, making standard platelet transfusions ineffective (a condition known as platelet refractoriness) [10][11][12]. Knowing your antibody status dictates exactly which medications will be used during surgery.
Systemic Treatments to Stop Bleeding
To manage the heavy bleeding risk of oral surgery, systemic (whole-body) treatments are administered through an IV right before and sometimes after the procedure [13][5]. The two primary options are:
- Recombinant Activated Factor VII (rFVIIa): This is a synthetic protein that bypasses the missing platelet function to help blood clot [10][14]. It is widely considered a highly effective and safe treatment for dental extractions in GT, particularly for patients who have developed antibodies against donor platelets [15][5][16].
- Platelet Transfusions: Donor platelets (ideally HLA-matched to reduce the risk of immune rejection) may be given if you do not have a history of platelet refractoriness [2][17].
In many cases, rFVIIa is used instead of or alongside platelets to ensure a stable clot forms and to limit the risk of developing new antibodies [10][18].
Stopping the Bleeding Locally: Protecting the Clot
Getting the blood to clot is only the first step; keeping the clot in place inside the mouth is equally challenging. Saliva contains enzymes designed to break down food, which also dissolve blood clots. Your oral surgeon will use local measures to stabilize the extraction site [19][20][6]:
- Antifibrinolytic Mouthwashes: Drugs like tranexamic acid (TXA) stop the body from breaking down clots [21][22]. Using a TXA mouthwash (often a 4.8% or 5% solution) for a week after the extraction is a standard, highly effective way to prevent secondary bleeding [23][24][25]. You will be instructed to gently swish and spit—do not swallow the mouthwash, and avoid vigorous swishing that could dislodge the clot.
- Hemostatic Packing: The surgeon may pack the empty tooth socket with dissolving materials like Gelfoam or localized clotting agents (such as liquid solutions that promote immediate clotting) that provide a physical scaffold for a clot to form on [19][26].
- Mechanical Pressure and Splints: Custom-made acrylic plates or soft surgical splints may be created before the surgery. These are placed over the gums post-extraction to apply constant physical pressure to the wound [27][1][10].
- Advanced Suturing: Surgeons often use specific stitching techniques (such as horizontal mattress sutures) that distribute tension evenly across the gums, holding the tissue tightly together and reducing the risk of bleeding [28][29]. Absorbable sutures are usually preferred so that a follow-up appointment to remove the stitches doesn’t accidentally tear the fragile clot [30][31].
Pain Management, Recovery, and Oral Hygiene
Pain management after dental surgery requires strict adherence to safe medications, as many common over-the-counter painkillers are dangerous for people with GT.
- Avoid NSAIDs Completely: Non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen (Advil, Motrin), naproxen (Aleve), and aspirin are strictly prohibited [32][6][9]. These drugs inhibit platelet function and will severely worsen your bleeding risk.
- Safe Pain Relief: Acetaminophen (Tylenol/paracetamol) is the recommended first-line painkiller because it does not interfere with platelet function [6][9]. For severe pain, such as after wisdom teeth removal, doctors may prescribe specific opioids, which are generally safe for your blood but must be used carefully [6][1].
Post-Operative Care Rules:
- Diet and Suction: Stick to soft, cool foods to avoid physically dislodging the clot or increasing blood flow to the mouth from heat [33][13]. Never use a straw, as the suction can easily pull the clot out of the socket.
- Oral Hygiene: It is important to keep your mouth clean to prevent infection, which increases bleeding risks. Gently brush your teeth, taking extreme care to avoid the surgical site.
- Recovery Timeline: The highest risk of bleeding is during the first 7 to 10 days while the tissue heals, which is why your TXA mouthwash and soft diet will likely last for a week [24].
Recognizing Emergencies: When to Seek Help
Even with meticulous planning, delayed bleeding can occur at home once you are discharged. You should have a clear emergency action plan coordinated with your hematologist before your surgery.
Seek immediate emergency medical care or contact your hematologist’s on-call emergency line if you experience:
- Continuous oozing or bleeding from the extraction site that does not stop after applying gentle pressure with gauze.
- Large, dark, “liver-like” blood clots forming in your mouth.
- Sudden swelling of your neck, jaw, or under your tongue, which can affect your breathing.
- Swallowing large amounts of blood, which may lead to nausea or vomiting dark material.
Common questions in this guide
Can I have my wisdom teeth removed at a standard dental clinic if I have Glanzmann Thrombasthenia?
What treatments are used to stop bleeding during oral surgery for GT?
Is it safe to take ibuprofen for pain after wisdom teeth removal with GT?
What should I do if I start bleeding after going home from oral surgery?
Will I need to stay in the hospital after having my wisdom teeth removed?
Questions for Your Doctor
5 questions
- •Have I been screened recently for alloantibodies, and will we be relying on rFVIIa or HLA-matched platelets for this surgery?
- •How many days should I expect to stay in the hospital for observation following the extractions?
- •Are you coordinating directly with my oral surgeon on the surgical stents and hemostatic packing to be used?
- •What specific concentration of tranexamic acid (TXA) mouthwash will be prescribed, and exactly how should I use it?
- •What is our exact emergency action plan if I start bleeding after I am discharged home, and who do I call after hours?
Questions for You
3 questions
- •What prior reactions have I had to blood or platelet transfusions that my care team needs to know about?
- •How far away do I live from the hospital, and how quickly could I get back to the emergency room if severe bleeding starts?
- •Who will stay with me during the first few days of recovery to monitor for prolonged oozing or unexpected complications?
References
References (33)
- 1
Oral Surgery in Patients With Glanzmann Thrombasthenia: A Case Series.
Segna E, Artoni A, Sacco R, Giannì AB
Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 2017; (75(2)):256-259 doi:10.1016/j.joms.2016.09.048.
PMID: 28341450 - 2
Perioperative administration of recombinant activated factor VII in a Glanzmann's thrombasthenia patient with platelet refractoriness: case report.
Bisinotto FMB, Martins LB, de Camargos GP, Bianco MP
Brazilian journal of anesthesiology (Elsevier) 2022; (72(6)):823-825 doi:10.1016/j.bjane.2021.09.021.
PMID: 34852265 - 3
Glanzmann's thrombasthenia: A nightmare for hernia surgeons.
Gandhi J, Gajjar A, Shinde P, Takalkar Y
Journal of minimal access surgery 2025; (21(4)):403-405 doi:10.4103/jmas.jmas_230_23.
PMID: 39095966 - 4
Successful Use of Hematopoietic Stem Cell Transplantation for 2 Pediatric Cases of Glanzmann Thrombasthenia and Review of the Literature.
Friend BD, Roach GD, Kempert PH, Moore TB
Journal of pediatric hematology/oncology 2020; (42(6)):e521-e526 doi:10.1097/MPH.0000000000001646.
PMID: 31693514 - 5
Oral invasive procedures in Glanzmann thrombasthenia: a retrospective observational study.
Delarue M, Severac F, Soell M, et al.
Research and practice in thrombosis and haemostasis 2024; (8(8)):102619 doi:10.1016/j.rpth.2024.102619.
PMID: 39660077 - 6
Glanzmann Thrombasthenia: Perspectives from Clinical Practice on Accurate Diagnosis and Optimal Treatment Strategies.
Mathews N, Rivard GE, Bonnefoy A
Journal of blood medicine 2021; (12()):449-463 doi:10.2147/JBM.S271744.
PMID: 34149292 - 7
Emergency management of patients with Glanzmann thrombasthenia: consensus recommendations from the French reference center for inherited platelet disorders.
Fiore M, Giraudet JS, Alessi MC, et al.
Orphanet journal of rare diseases 2023; (18(1)):171 doi:10.1186/s13023-023-02787-2.
PMID: 37386449 - 8
Should HLA and HPA-matched platelet transfusions for patients with Glanzmann Thrombasthenia or Bernard-Soulier syndrome be standardized care? A Dutch survey and recommendations.
Huisman EJ, Holle N, Schipperus M, et al.
Transfusion 2024; (64(5)):824-838 doi:10.1111/trf.17824.
PMID: 38642032 - 9
How we treat the platelet glycoprotein defects; Glanzmann thrombasthenia and Bernard Soulier syndrome in children and adults.
Grainger JD, Thachil J, Will AM
British journal of haematology 2018; (182(5)):621-632 doi:10.1111/bjh.15409.
PMID: 30117143 - 10
The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention.
Poon MC, d'Oiron R, Zotz RB, et al.
Haematologica 2015; (100(8)):1038-44 doi:10.3324/haematol.2014.121384.
PMID: 26001792 - 11
New Insights Into the Treatment of Glanzmann Thrombasthenia.
Poon MC, Di Minno G, d'Oiron R, Zotz R
Transfusion medicine reviews 2016; (30(2)):92-9.
PMID: 26968829 - 12
Outcomes of recombinant activated factor VIIa (NovoSeven) therapy in glanzmann thrombasthenia: two case reports.
Almatar E, Alsharidah S, Hashem OA
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2025; (36(6)):293-295 doi:10.1097/MBC.0000000000001380.
PMID: 40673721 - 13
Inherited Platelet Disorders: Diagnosis and Management.
Al-Huniti A, Kahr WH
Transfusion medicine reviews 2020; (34(4)):277-285 doi:10.1016/j.tmrv.2020.09.006.
PMID: 33082057 - 14
Efficacy and safety of recombinant activated factor VII in Glanzmann thrombasthenia: A systematic literature review.
Saultier P, Grino M, Falaise C, et al.
Haemophilia : the official journal of the World Federation of Hemophilia 2025; (31(1)):7-15 doi:10.1111/hae.15130.
PMID: 39604156 - 15
Eptacog alfa activated: a recombinant product to treat rare congenital bleeding disorders.
Di Minno G
Blood reviews 2015; (29 Suppl 1()):S26-33.
PMID: 26073366 - 16
The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia.
Poon MC
Thrombosis and haemostasis 2021; (121(3)):332-340 doi:10.1055/s-0040-1718373.
PMID: 33124022 - 17
High Rates of Anti-αIIbβ3 Antibodies Produced by a Glanzmann Thrombasthenia Patient after First and Unique Red Blood Cells Administration.
Huguenin Y, Levoir L, Bouton M, Fiore M
Acta haematologica 2023; (146(1)):44-46 doi:10.1159/000526224.
PMID: 36103848 - 18
The international, prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes of non-surgical bleeding episodes in patients with Glanzmann thrombasthenia.
Di Minno G, Zotz RB, d'Oiron R, et al.
Haematologica 2015; (100(8)):1031-7 doi:10.3324/haematol.2014.121475.
PMID: 26001793 - 19
Glanzmann thrombasthenia: Use of hemocoagulase (BotroClot) for arrest of bleeding during a primary tooth endodontic procedure.
Jairam LS, Kotha SB
Indian journal of dental research : official publication of Indian Society for Dental Research 2022; (33(2)):219-222 doi:10.4103/ijdr.ijdr_1191_21.
PMID: 36254965 - 20
Perioperative Hemostatic Management of a Pediatric Patient with Glanzmann Thrombasthenia Undergoing Osteoplastic Craniotomy and Hematoma Removal: A Case Report.
Lee SM, Kim KN, Kim SY
Acta haematologica 2019; (142(4)):244-248 doi:10.1159/000499362.
PMID: 31085914 - 21
A point mutation in Phe71Ser in glycoprotein IX as a genetic cause of Bernard-Soulier syndrome: case report.
Alsahafi IK, Al-Harbi I, Aldor SM, et al.
Clinical case reports 2018; (6(4)):686-689 doi:10.1002/ccr3.1427.
PMID: 29636940 - 22
Acquired platelet function disorders.
Brennan Y, Levade M, Ward CM
Thrombosis research 2020; (196()):561-568 doi:10.1016/j.thromres.2019.06.009.
PMID: 31229273 - 23
Local haemostatic measures after tooth removal in patients on antithrombotic therapy: a systematic review.
Ockerman A, Miclotte I, Vanhaverbeke M, et al.
Clinical oral investigations 2019; (23(4)):1695-1708 doi:10.1007/s00784-018-2576-x.
PMID: 30155575 - 24
Topical application of tranexamic acid in anticoagulated patients undergoing minor oral surgery: A systematic review and meta-analysis of randomized clinical trials.
de Vasconcellos SJ, de Santana Santos T, Reinheimer DM, et al.
Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 2017; (45(1)):20-26 doi:10.1016/j.jcms.2016.10.001.
PMID: 27840121 - 25
Local Tranexamic Acid for Preventing Hemorrhage in Anticoagulated Patients Undergoing Dental and Minor Oral Procedures: A Systematic Review and Meta-Analysis.
Zaib A, Shaheryar M, Shakil M, et al.
Healthcare (Basel, Switzerland) 2022; (10(12)) doi:10.3390/healthcare10122523.
PMID: 36554047 - 26
Total Extraction as a Treatment for Anaemia in a Patient of Glanzmann's Thrombasthenia with Chronic Gingival Bleed: Case Report.
Ghosh A, Kumar S, Chacko R, Charlu AP
Journal of clinical and diagnostic research : JCDR 2016; (10(1)):ZD11-2 doi:10.7860/JCDR/2016/16383.7123.
PMID: 26894187 - 27
Glanzmann Thrombasthenia: Use of the Soft Splint with Tranexamic Acid Paste to Reduce Spontaneous Oral Bleeding.
Bhavyaa R, Vignesh KC, Muthu MS, et al.
International journal of clinical pediatric dentistry 2021; (14(4)):580-585 doi:10.5005/jp-journals-10005-1973.
PMID: 34824518 - 28
Simple versus horizontal mattress suture configuration in bankart repair.
Connaughton AJ, Kluczynski MA, Marzo JM
Journal of orthopaedics 2021; (23()):225-226 doi:10.1016/j.jor.2021.01.012.
PMID: 33642819 - 29
Biomechanical Evaluation of Knotless and Knotted All-Suture Anchor Repair Constructs in 4 Bankart Repair Configurations.
Lacheta L, Brady A, Rosenberg SI, et al.
Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association 2020; (36(6)):1523-1532 doi:10.1016/j.arthro.2020.01.046.
PMID: 32057982 - 30
Deep and Superficial Closure.
Beidas OE, Gusenoff JA
Aesthetic surgery journal 2019; (39(Suppl_2)):S85-S93 doi:10.1093/asj/sjy208.
PMID: 30869753 - 31
Assessment of the Mechanical Properties of Different Suture Materials for Oral Surgery: An In Vitro Tensile Strength Study.
Kaur Randhawa R, Dubey T, Pansuriya I, et al.
Cureus 2024; (16(8)):e65952 doi:10.7759/cureus.65952.
PMID: 39221394 - 32
Pregnancy and Delivery Management With Recombinant Factor VIIa in a Glanzmann Thrombasthenia Patient: A Case Report.
Enciso L, Aragón-Mendoza RL, León LA, Torres-Torres CG
Cureus 2022; (14(2)):e22570 doi:10.7759/cureus.22570.
PMID: 35355542 - 33
Inherited platelet functional disorders: General principles and practical aspects of management.
Lee A, Poon MC
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2018; (57(4)):494-501 doi:10.1016/j.transci.2018.07.010.
PMID: 30031712
This page provides educational information about managing dental procedures with Glanzmann Thrombasthenia. Always consult your hematologist and oral surgeon to develop a safe, personalized surgical plan before undergoing any dental work.
Get notified when new evidence is published on Glanzmann Thrombasthenia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.